LUNAR1 and neoplasm: In CRC patients with increased LUNAR1 expression, the adjusted HR of unfavourable prognosis was 2.79 (95% CI: 1.56–4.99, P < 0.001) compared with that of patients with tumours of preserved LUNAR1 expression.